ADULT;
AGED;
AGED, 80 AND OVER;
ARTHRITIS, INFECTIOUS;
CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS;
COMMUNICABLE DISEASES;
DISEASE OUTBREAKS;
DRUG COMPOUNDING;
DRUG CONTAMINATION;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
MALE;
MIDDLE AGED;
MYCOSES;
YOUNG ADULT;
Centers for Disease Control and Prevention. Multistate fungal meningitis outbreak investigation. Accessed 18 November 2012.
Centers for Disease Control and Prevention. Multistate fungal meningitis outbreak investigation. Available at: http://www.cdc.gov/hai/outbreaks/ currentsituation/. Accessed 18 November 2012.
2
84873662219
Centers for Disease Control and Prevention. Multistate meningitis outbreak investigation: healthcare facilities. Accessed 18 November 2012.
Centers for Disease Control and Prevention. Multistate meningitis outbreak investigation: healthcare facilities. Available at: http://www. cdc.gov/hai/outbreaks/meningitis-facilities-map.html. Accessed 18 November 2012.
3
84873626023
Centers for Disease Control and Prevention. Multistate fungal meningitis outbreak investigation: current case count . Accessed 18 November 2012.
Centers for Disease Control and Prevention. Multistate fungal meningitis outbreak investigation: current case count. Available at: http://www.cdc.gov/ hai/outbreaks/meningitis-map.html. Accessed 18 November 2012.
4
84873630149
Centers for Disease Control and Prevention. Fungal diseases: other pathogenic fungi. Accessed 18 November 2012.
Centers for Disease Control and Prevention. Fungal diseases: other pathogenic fungi. Available at: http://www.cdc.gov/fungal/other/index. html. Accessed 18 November 2012.
5
0037074036
Centers for Disease Control and Prevention. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy-United States, July-November 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1109-12. Accessed 18 November 2012.
Centers for Disease Control and Prevention. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy-United States, July-November 2002. MMWR Morb Mortal Wkly Rep 2002; 51:1109-12. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5149a1.htm. Accessed 18 November 2012.
6
84873683943
Centers for Disease Control and Prevention. Multistate outbreak of fungal infection associated with infection of methylprednisolone acetate solution from a single compounding pharmacy-United States, 2012. Accessed 18 November 2012.
Centers for Disease Control and Prevention. Multistate outbreak of fungal infection associated with infection of methylprednisolone acetate solution from a single compounding pharmacy-United States, 2012. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm61e1012a1.htm?s-cid=mm61e1012a1-w. Accessed 18 November 2012.
7
84873661368
Centers for Disease Control and Prevention. Multistate fungal infections outbreak investigation: case definitions for meningitis and septic arthritis. Accessed 18 November 2012.
Centers for Disease Control and Prevention. Multistate fungal infections outbreak investigation: case definitions for meningitis and septic arthritis. Available at: http://www.cdc.gov/hai/outbreaks/clinicians/casedef-multistate- outbreak.html. Accessed 18 November 2012.
8
84873627083
CDC Health Alert Network. Contamination identified in additional medical products from New England Compounding Center. Accessed 18 November 2012.
CDC Health Alert Network. Contamination identified in additional medical products from New England Compounding Center. Available at: http://www.bt.cdc. gov/HAN/han00333.asp. Accessed 18 November 2012.
9
84873673782
Accessed 18 November
Lyons JL, Gireesh ED, Trivedi JB, et al. Fatal Exserohilum meningitis and central nervous system vasculitis after cervical epidural methylprednisolone injection. Ann Intern Med [Epub ahead of print]. Available at: http://annals.org/article.aspx?articleID=1384432. Accessed 18 November 2012.
Pettit AC, Kropski JA, Castilho JL, et al. The index case for the fungal meningitis outbreak in the United States. New Engl J Med 2012 [Epub ahead of print]. Available at: http://www.nejm.org/doi/full/10. 1056/NEJMoa1212292?query= OF. Accessed 18 November 2012.
Kauffman CA, Pappas PG, Patterson TF. Fungal infections associated with contaminated methylprednisolone injections: preliminary report. New Engl J Med 2012 [Epub ahead of print]. Available at: http://www. nejm.org/doi/full/10.1056/ NEJMra1212617?query=OF. Accessed 18 November 2012.
Centers for Disease Control and Prevention. Diagnostic testing and specimen shipping for central nervous system and parameningeal infections Accessed 18 November 2012.
Centers for Disease Control and Prevention. Diagnostic testing and specimen shipping for central nervous system and parameningeal infections. Available at: http://www.cdc.gov/hai/outbreaks/clinicians/instructions- testingandsubmission.html. Accessed 18 November 2012.
13
84873633844
Centers for Disease Control and Prevention. Interim treatment guidance for central nervous system (CNS) and parameningeal infections associated with injection of contaminated steroid products . Accessed 18 November 2012.
Centers for Disease Control and Prevention. Interim treatment guidance for central nervous system (CNS) and parameningeal infections associated with injection of contaminated steroid products. Available at: http://www.cdc.gov/ hai/outbreaks/clinicians/guidance-cns.html. Accessed 18 November 2012.
14
0042331273
Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients
Accessed 18 November 2012
Lutsar I, Roffey S, Troke P. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin Infect Dis 2003; 37:728-32. Available at: http://cid. oxfordjournals.org/content/37/5/728.full. Accessed 18 November 2012.
Centers for Disease Control and Prevention. Interim treatment guidance for osteoarticular infections associated with injection of contaminated steroid products. Accessed 18 November 2012.
Centers for Disease Control and Prevention. Interim treatment guidance for osteoarticular infections associated with injection of contaminated steroid products. Available at: http://www.cdc.gov/hai/outbreaks/clinicians/interim- guidance-osteoarti cular-infections.html. Accessed 18 November 2012.
16
84873619762
Centers for Disease Control and Prevention. Guidance on management of asymptomatic patients who received epidural or paraspinal injections with contaminated steroid products. Accessed 18 November 2012.
Centers for Disease Control and Prevention. Guidance on management of asymptomatic patients who received epidural or paraspinal injections with contaminated steroid products. Available at: http://www.cdc.gov/hai/outbreaks/ clinicians/guidance-asymptomatic-persons. html. Accessed 18 November 2012.
17
84873646236
Centers for Disease Control and Prevention. Interim guidance for management of asymptomatic persons exposed to potentially contaminated steroid products. Antifungal prophylaxis for patients who received intra-articular injections with potentially contaminated steroid products. Accessed 18 November 2012.
Centers for Disease Control and Prevention. Interim guidance for management of asymptomatic persons exposed to potentially contaminated steroid products. Antifungal prophylaxis for patients who received intra-articular injections with potentially contaminated steroid products. Available at: http://www.cdc.gov/hai/outbreaks/clinicians/interim-guidance-asymptomatic- persons.html. Accessed 18 November 2012.
* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.